These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 37300664)

  • 1. Supplements for Lipid Lowering: What Does the Evidence Show?
    Mirzai S; Laffin LJ
    Curr Cardiol Rep; 2023 Aug; 25(8):795-805. PubMed ID: 37300664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?
    Cicero AFG; Fogacci F; Stoian AP; Vrablik M; Al Rasadi K; Banach M; Toth PP; Rizzo M
    Curr Atheroscler Rep; 2021 Aug; 23(10):57. PubMed ID: 34345932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional foods and dietary supplements for the management of dyslipidaemia.
    Hunter PM; Hegele RA
    Nat Rev Endocrinol; 2017 May; 13(5):278-288. PubMed ID: 28133369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol-Lowering Nutraceuticals Affecting Vascular Function and Cardiovascular Disease Risk.
    Bianconi V; Mannarino MR; Sahebkar A; Cosentino T; Pirro M
    Curr Cardiol Rep; 2018 May; 20(7):53. PubMed ID: 29802549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-modifying effects of nutraceuticals: An evidence-based approach.
    Sahebkar A; Serban MC; Gluba-Brzózka A; Mikhailidis DP; Cicero AF; Rysz J; Banach M
    Nutrition; 2016; 32(11-12):1179-92. PubMed ID: 27324061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Joint position statement on "Nutraceuticals for the treatment of hypercholesterolemia" of the Italian Society of Diabetology (SID) and of the Italian Society for the Study of Arteriosclerosis (SISA).
    Pirro M; Vetrani C; Bianchi C; Mannarino MR; Bernini F; Rivellese AA
    Nutr Metab Cardiovasc Dis; 2017 Jan; 27(1):2-17. PubMed ID: 27956024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diet and Cardiovascular Disease Risk Among Individuals with Familial Hypercholesterolemia: Systematic Review and Meta-Analysis.
    Barkas F; Nomikos T; Liberopoulos E; Panagiotakos D
    Nutrients; 2020 Aug; 12(8):. PubMed ID: 32823643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Effects of Low-Dose Rosuvastatin, Placebo, and Dietary Supplements on Lipids and Inflammatory Biomarkers.
    Laffin LJ; Bruemmer D; Garcia M; Brennan DM; McErlean E; Jacoby DS; Michos ED; Ridker PM; Wang TY; Watson KE; Hutchinson HG; Nissen SE
    J Am Coll Cardiol; 2023 Jan; 81(1):1-12. PubMed ID: 36351465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Monacolins and Berberine in Food Supplements for Lipid Control: An Overview of Products Sold on the Italian Market.
    Marcheluzzo S; Faggian M; Zancato M; Peron G
    Molecules; 2021 Apr; 26(8):. PubMed ID: 33921464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerability and safety of commonly used dietary supplements and nutraceuticals with lipid-lowering effects.
    Cicero AF; Ferroni A; Ertek S
    Expert Opin Drug Saf; 2012 Sep; 11(5):753-66. PubMed ID: 22788832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice: A Multicenter Study.
    Cicero AF; Derosa G; Pisciotta L; Barbagallo C;
    J Med Food; 2015 Nov; 18(11):1270-3. PubMed ID: 26274827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is it possible to decrease cholesterol levels with dietary supplements?].
    Rodondi PY; Degoumois F; Marques-Vidal P; Rodondi N
    Rev Med Suisse; 2016 Mar; 12(508):451-3. PubMed ID: 27089602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary interventions (plant sterols, stanols, omega-3 fatty acids, soy protein and dietary fibers) for familial hypercholesterolaemia.
    Malhotra A; Shafiq N; Arora A; Singh M; Kumar R; Malhotra S
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD001918. PubMed ID: 24913720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marked variability of monacolin levels in commercial red yeast rice products: buyer beware!
    Gordon RY; Cooperman T; Obermeyer W; Becker DJ
    Arch Intern Med; 2010 Oct; 170(19):1722-7. PubMed ID: 20975018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Red Yeast Rice Preparations: Are They Suitable Substitutions for Statins?
    Dujovne CA
    Am J Med; 2017 Oct; 130(10):1148-1150. PubMed ID: 28601545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypolipaemic nutraceutics: red yeast rice and Armolipid, berberine and bergamot.
    Kłosiewicz-Latoszek L; Cybulska B; Stoś K; Tyszko P
    Ann Agric Environ Med; 2021 Mar; 28(1):81-88. PubMed ID: 33775071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combinations of phytomedicines with different lipid lowering activity for dyslipidemia management: The available clinical data.
    Cicero AF; Colletti A
    Phytomedicine; 2016 Oct; 23(11):1113-8. PubMed ID: 26621556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of Nutraceuticals with Lipid Lowering Properties.
    Poli A; Visioli F
    High Blood Press Cardiovasc Prev; 2019 Apr; 26(2):113-118. PubMed ID: 30877602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Red yeast rice, monacolin K, and pleiotropic effects.].
    Cicero AFG
    Recenti Prog Med; 2018 Feb; 109(2):154e-157e. PubMed ID: 29493648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of treatment with monacolin K, berberine and coenzyme Q10 on lipid metabolism in patients with moderate cardiovascular risk.
    Martinez-Martin F; Corbella E; Sarasa I; Trias F; Petitbò D; Licerán M; Sánchez-Hernández RM; Martin D; Sánchez A; Arnás C; de Dios S; Florido M; Pintó X
    Semergen; 2022 Sep; 48(6):403-410. PubMed ID: 35606250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.